نتائج البحث - Nadia Daizadeh

تنقيح النتائج
  1. 1
    RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk

    RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosi... حسب Elizabeth J. Samelson, Paul D. Miller, Claus Christiansen, Nadia Daizadeh, Luanda Grazette, Mary S. Anthony, Ogo Egbuna, Andrea Wang, Suresh Siddhanti, Angela M. Cheung, Nathalie Franchimont, Douglas P. Kiel

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab

    Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab حسب Heinz Wiendl, Matthew Carraro, Cristoforo Comi, Guillermo Izquierdo, Ho Jin Kim, Basil Sharrack, Carlo Tornatore, Nadia Daizadeh, Luke Chung, Alice K. Jacobs, Richard Hogan, Linda V. Wychowski, Bart Van Wijmeersch

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study

    Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study حسب Sibyl Wray, Eva Havrdová, David R. Snydman, Douglas L. Arnold, Jeffrey Cohen, Alasdair Coles, Hans‐Peter Hartung, Krzysztof Selmaj, Howard L. Weiner, Nadia Daizadeh, David Margolin, Madalina Chirieac, D. A. S. Compston

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials

    Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized pl... حسب Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert, Leda Mannent, Giorgio Walter Canonica, Joseph K. Han, Jorge Máspero, César Picado, Nadia Daizadeh, Benjamin Ortiz, Yongtao Li, Marcella Ruddy, Elizabeth Laws, Nikhil Amin

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures

    A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures حسب Emil H. Schemitsch, Theodore Miclau, Theofilos Karachalios, Lauren L. Nowak, Parag Sancheti, Rudolf W. Poolman, John Caminis, Nadia Daizadeh, Ricardo E. Dent-Acosta, Ogo Egbuna, Arkadi Chines, Judy Maddox, Andreas Grauer, Mohit Bhandari

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline

    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline حسب Arnaud Bourdin, J. Christian Virchow, Alberto Papi, Njira Lugogo, Philip G. Bardin, Martti Antila, David Halpin, Nadia Daizadeh, Michel Djandji, Benjamin Ortiz, Juby A. Jacob‐Nara, Rebecca Gall, Yamo Deniz, Paul J. Rowe

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial

    Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial حسب Alasdair Coles, Douglas L. Arnold, Ann Bass, Aaron Boster, D. A. S. Compston, Óscar Fernández, Eva Havrdová, Kunio Nakamura, Anthony Traboulsee, Tjalf Ziemssen, Alice K. Jacobs, David Margolin, Xiaobi Huang, Nadia Daizadeh, Madalina Chirieac, Krzysztof Selmaj

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

    Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years حسب Serge Ferrari, Jonathan D. Adachi, Kurt Lippuner, Carol Zapalowski, Paul D. Miller, Jean‐Yves Reginster, Ove Törring, David L. Kendler, Nadia Daizadeh, A. Wang, C. D. O’Malley, Rachel B. Wagman, Cesar Libanati, E. Michael Lewiecki

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223

    Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223 حسب Brian Steingo, Yaser Al Malik, Ann Bass, Regina Berkovich, Matthew Carraro, Óscar Fernández, Carolina Ionete, Luca Massacesi, Sven G. Meuth, Dimos D. Mitsikostas, Gabriel Pardo, Renata Simm, Anthony Traboulsee, Zia Choudhry, Nadia Daizadeh, D. A. S. Compston

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

    Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma حسب Ian Pavord, Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara, Nadia Daizadeh, Benjamin Ortiz, Robert R. Johnson, Sivan Harel, Michel Djandji, Ledia Goga, Nora Crikelair, Paul J. Rowe, William W. Busse

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps

    Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps حسب Joaquim Mullol, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W. Hellings, Joseph K. Han, R. Jankowski, Jan Vodička, Philippe Gevaert, Nadia Daizadeh, Asif Khan, Siddhesh Kamat, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda Mannent

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma

    Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma حسب Nikolaos G. Papadopoulos, Stanley J. Szefler, Leonard B. Bacharier, Jorge Máspero, Christian Domingo, Alessandro Fiocchi, Jason K. Lee, Nadia Daizadeh, David J. Lederer, Megan Hardin, Rebecca Gall, Michel Djandji, Shahid Siddiqui, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study

    Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study حسب Tjalf Ziemssen, Ann Bass, Regina Berkovich, Giancarlo Comi, Sara Eichau, Jeremy Hobart, Samuel F. Hunter, Christopher LaGanke, Volker Limmroth, Daniel Pelletier, Carlo Pozzilli, Sven Schippling, Lívia Sousa, Anthony Traboulsee, Bernard M.J. Uitdehaag, Bart Van Wijmeersch, Zia Choudhry, Nadia Daizadeh, B. Singer

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

    Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis حسب Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro, Parameswaran Nair, D. Staumont‐Sallé, Amr Radwan, Robert R. Johnson, Upender Kapoor, Faisal A. Khokhar, Nadia Daizadeh, Zhen Chen, Elizabeth Laws, Benjamin Ortiz, Juby A. Jacob‐Nara, Leda Mannent, Paul J. Rowe, Yamo Deniz

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years

    Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years حسب Jiwon Oh, Anat Achiron, Elisabeth Gulowsen Celius, Christina Chambers, Joy Derwenskus, Virginia Devonshire, Kerstin Hellwig, George J. Hutton, Pamela McCombe, Marie Moore, David Rog, Jean-Raphael Schneider, Renata Simm, Lívia Sousa, Stephen G. Vincent, Luke Chung, Nadia Daizadeh, Colin Mitchell, D. A. S. Compston

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma

    Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma حسب Ashish Bansal, Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Andrew Blauvelt, Marjolein de Bruin‐Weller, Jonathan Corren, Lawrence Sher, Emma Guttman‐Yassky, Zhen Chen, Nadia Daizadeh, Mohamed Kamal, Brad Shumel, Paola Mina‐Osorio, Leda Mannent, Naimish Patel, Neil M.H. Graham, Faisal A. Khokhar, Marius Ardeleanu

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study حسب Socrates E. Papapoulos, Kurt Lippuner, Christian Roux, Celia J. F. Lin, David L. Kendler, E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, P. Lakatos, C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, A. Wang, Marc A. Gavin, Cesar Libanati, Rachel B. Wagman, Henry G. Bone

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases

    Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases حسب Giorgio Walter Canonica, Arnaud Bourdin, Anju T. Peters, Martin Desrosiers, Claus Bachert, Stephan Weidinger, Eric L. Simpson, Nadia Daizadeh, Zhen Chen, Siddhesh Kamat, Asif Khan, Jingdong Chao, Neil M.H. Graham, Elizabeth Laws, Ana B. Rossi, Marius Ardeleanu, Leda Mannent, Nikhil Amin, Benjamin Ortiz, Yamo Deniz, Michel Djandji, Paul J. Rowe

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

    Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction حسب Nicola A. Hanania, Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald, Jorge Máspero, Constance H. Katelaris, Dave Singh, Nadia Daizadeh, Arman Altincatal, Nami Pandit‐Abid, Xavier Soler, Shahid Siddiqui, Elizabeth Laws, Juby A. Jacob‐Nara, Paul J. Rowe, David J. Lederer, Megan Hardin, Yamo Deniz

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

    Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension حسب Socrates E. Papapoulos, Roland Chapurlat, Cesar Libanati, Maria Luisa Brandi, Jacques P. Brown, E. J. Czerwiński, Marc-Antoine Krieg, Z. Man, Dan Mellström, S. Radominski, Jean‐Yves Reginster, Heinrich Resch, José Andrés Román Ivorra, Christian Roux, Eric Vittinghoff, Matthew Austin, Nadia Daizadeh, Michelle N. Bradley, Andreas Grauer, Steven R. Cummings, Henry G. Bone

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: